McKeown: Early diagnosis of FH is key

Promoted content

“The problem with FH has been that patients with the condition are often not diagnosed till later on in life,” said Scott McKeown, Molecular Product Manager at Random Biosciences.

Speaking to EURACTIV at a conference on cardiovascular diseases in Glasgow, McKeown said that a late diagnosis of Familial Hipercholesterolemia, or FH, means that patients “have accumulated quite a lot of fatty debris in blood vessels, which makes them more exposed to a cardiovascular event.”

Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels in the blood and early cardiovascular disease.

Subscribe to our newsletters

Subscribe
Contribute